Neuroprotective Agents in Brain Injury: A Partial Failure?

被引:10
|
作者
Barreto, George E. [1 ]
Gonzalez, Janneth [1 ]
Capani, Francisco [2 ,3 ]
Morales, Ludis [1 ]
机构
[1] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia
[2] Univ Argentina JF Kennedy, Dept Biol, Buenos Aires, DF, Argentina
[3] Inst Invest Cardiol, Lab Citoarquitectura & Plasticidad Neuronal, Buenos Aires, DF, Argentina
关键词
astrocytes; brain injury; clinical trials; neurons; neuroprotection; ESTROGEN-RECEPTOR; CELL-DEATH; ASTROCYTES; SIMVASTATIN; RATS; PROGESTERONE; INFARCTION; ASTROGLIA; PROTECTS; BENEFITS;
D O I
10.3109/00207454.2011.648292
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain injury leads to inflammation, stress, and cell death. Neurons are more susceptible to injury than astrocytes, as they have limited antioxidant capacity, and rely heavily on their metabolic coupling with astrocytes to combat oxidative stress. Both normally and after brain injury, astrocytes support neurons by providing antioxidant protection, substrates for neuronal metabolism, and glutamate clearance. Although astrocytes are generally more resilient than neurons after injury, severe damage also results in astrocyte dysfunction, leading to increased neuronal death. This mini review provides a very insightful and brief overview on a few examples of promising neuroprotective compounds targeting astrocyte function, with specific attention on how these treatments alter astrocyte response or viability, and how this may be critical for neuronal survival following brain injury.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [1] Neuroprotective agents in traumatic brain injury
    Maas, AIR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (04) : 753 - 767
  • [2] Cannabinoids as neuroprotective agents in traumatic brain injury
    Biegon, A
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) : 2177 - 2183
  • [3] Neuroprotective agents for neonatal hypoxic-ischemic brain injury
    Wu, Qiaofeng
    Chen, Wu
    Sinha, Bharati
    Tu, Yanyang
    Manning, Simon
    Thomas, Niranjan
    Zhou, Shuanhu
    Jiang, Hong
    Ma, He
    Kroessler, Daphne A.
    Yao, Jiemin
    Li, Zhipu
    Inder, Terry E.
    Wang, Xin
    DRUG DISCOVERY TODAY, 2015, 20 (11) : 1372 - 1381
  • [4] Exogenous Ketone Bodies as Promising Neuroprotective Agents for Developmental Brain Injury
    Wood, Thomas R.
    Stubbs, Brianna J.
    Juul, Sandra E.
    DEVELOPMENTAL NEUROSCIENCE, 2019, 40 (5-6) : 451 - 462
  • [5] Selective COX-2 Inhibitors as Neuroprotective Agents in Traumatic Brain Injury
    Hiskens, Matthew I.
    Schneiders, Anthony G.
    Fenning, Andrew S.
    BIOMEDICINES, 2024, 12 (08)
  • [6] Neuroprotective agents in severe head injury
    Fearnside, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (08) : S54 - S55
  • [7] Neuropeptides: Potential neuroprotective agents in ischemic injury
    Saklani, Priyanka
    Khan, Heena
    Gupta, Saurabh
    Kaur, Amarjot
    Singh, Thakur Gurjeet
    LIFE SCIENCES, 2022, 288
  • [8] Is genistein neuroprotective in traumatic brain injury?
    Soltani, Zahra
    Khaksari, Mohammad
    Jafari, Elham
    Iranpour, Maryam
    Shahrokhi, Nader
    PHYSIOLOGY & BEHAVIOR, 2015, 152 : 26 - 31
  • [9] Neuroprotective Strategies in Neonatal Brain Injury
    Parikh, Pratik
    Juul, Sandra E.
    JOURNAL OF PEDIATRICS, 2018, 192 : 22 - 32
  • [10] Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
    Machado, Noelia D.
    Armas, Gorka Villena
    Fernandez, Mariana A.
    Grijalvo, Santiago
    Diaz, David Diaz
    NEUROSCI, 2021, 2 (03): : 305 - 319